24 Apr 2024
Q1 Trading Update – 2024
Good Q1 Performance. On track for full year delivery
1 minute read

Press release
Download PDFShare to
Featured
Why Prevention and Informed Health Decisions Matter in the Fight Against Antimicrobial Resistance
Building healthier, more resilient communities starts with the choices we make every day.
Learn moreFrom A Simple Scientific Question To The World’s Go-To Heartburn & Indigestion Brand
How Gaviscon grew to define digestive self-care
Learn moreShare price
Share price
Featured
At what cost? How Access to Water Unlocks Everything Else
Every person on earth needs access to water.
Learn moreShare price
Share price
Share price
Share price
Share price
Good Q1 Performance. On track for full year delivery
"We have delivered a good first quarter. Following a period of price-led growth, we are now returning to a more balanced contribution from price, mix and volume. We grew volumes in many of our powerbrands in the quarter, including Lysol, Dettol, Durex and Finish, as well as our non-seasonal OTC portfolio. In addition, we continue to benefit from carryover pricing and consumers trading up to our premium innovations."
Chief Executive Officer